Publications

DTG/3TC is non-inferior to DTG-based 3-drug ART in children with HIV: D3/Penta 21 week-96 results

2026

Authors: Turkova A, Chan MK, Kekitiinwa AR, Mutuluuza CK, Musoke P, Cressey TR, Violari A, Archary M, Variava E, Rojo P, Welch SB, Thomason MJ, Giaquinto C, Ford D.

Presented at: CROI 2026

Proactive vs. reactive COVID-19 screening in schools: Lessons from experimental protocols in France during the Delta and Omicron waves

2026

Authors: Colosi E, Lina B, Elias C, Vanhems P, Colizza V.

Published in: PNAS Nexus

Empirical treatment against cytomegalovirus and tuberculosis in severe pneumonia in HIV-infected infants: a randomized controlled clinical trial

2026

Authors: Moraleda C, Rojo P, Dominguez S, Dominguez S, Buck CW, Musiime V, Mujuru HA, Chabala C, Mvalo T, Bramugy J, Madrid L, Sacarlal J, Ghambi L, Fernandez-Luis S, Bates M, Tagarro A.

Presented at: CROI 2026

Sex matters: A Bayesian approach to analyzing sex differences in an African pediatric cohort

2026

Authors: Gastesi Orbegozo I, Ballesteros A, Barnabas S, Barnabas S, Behuhuma O, Lain MG, Nhampossa T, Otwombe K, Rossi P, Giaquinto C, Kuhn L, Reddy K, Cotugno N, Rojo P, Tagarro A, Dominguez-Rodriguez S; on behalf of the EPIICAL consortium.

Presented at: CROI 2026

Prime-boost HIVIS DNA and MVA-CMDR regimen induces robust Env and Gag antibody responses in youth living with HIV

2026

Authors: Kim J, Slike B, McCarragher C, Nguyen P, Metzger L, Moreland S, Pinyakorn S, Schluck G, Krebs S, Rao M, Palma P, Robb M; on behalf of the RV534 study group.M, Cotugno N, Maldarelli F, Palma P, Spiegel H, Robb M, Persaud D; on behalf of the RV534 Study Group.

Presented at: CROI 2026

HIV-1 DNA dynamics with HIVIS DNA/MVA-CDMR vaccinations +/-TLR4 Agonist: the HVRRICANE trial

2026

Authors: Dhummakupt A, Szewczyk J, Barnabas S, Cotton M, Gorelick R, Pinyakorn S, Turk E, DeSouza M, Cotugno N, Maldarelli F, Palma P, Spiegel H, Robb M, Persaud D; on behalf of the RV534 Study Group.

Presented at: CROI 2026

Pharmacokinetics of a Novel Dose Ratio of DTG/FTC/TAF for African Children with HIV (UNIVERSAL1)

2026

Authors: Kamphuis AEM, Mujuru HA, Bwakura-Dangarembizi MF, Kisitu GP, Matovu F, Kaudha E, Mulindwa A, Jacobs TG, Salvadori N, Than-in-at K, Cressey TR, Nardone A, Lallemant M, Burger DM, for the UNIVERSAL1 Trial Team.

Presented at: CROI 2026

SHIELD study: a multicenter, open-label, single-arm trial to evaluate the safety, pharmacokinetics and antiviral activity of fostemsavir in combination with optimized background therapy (OBT) in children and adolescents with HIV who are failing their current combination antiretroviral therapy (cART) and have dual- or triple-class antiretroviral (ARV) resistance

2026

Authors: Grasa C, Salvadori N, Nardone A, Than-in-at K, Koblansky A, Parry C, Thakkar N, Wang M, Giaquinto C, Rojo P & Cressey RT

Published in: BMC Infectious Diseases

Paediatric infection hospital admissions in England before, during and after the COVID-19 pandemic

2026

Authors: Jackson C, Wijlaars L, Abdullahi F, Liu M, Judd A, Thorne C, Collins IJ, Di Chiara C, Hardelid P.

Published in: Epidemiology and Infection

Implementation of optimized kangaroo care for infection prevention and control in neonatal intensive care units (NeoIPC): Protocol for the implementation elements of a multicenter parallel cluster randomized hybrid type 2 implementation-effectiveness study

2026

Authors: Schultes MT, Baenziger J, Nyantakyi E, Wu CX, Ferrari G, Sieswerda E, van Werkhoven CH, Minotti C, Wolfensberger A, Tediosi F, D’Ambrosio F, Bielicki JA, Clack L, and the NeoIPC Consortium.

Published in: Implementation Science

Methodological framework for the surveillance of healthcare-associated infections in high-risk infants: the NeoIPC surveillance core module protocol

2026

Authors: Karadağ G, Bekker A, Dramowski A, Loureiro Gonzalez B, Pérez López J, Pijoan Zubizarreta JI, Heath PT, Aghdassi SJS, Piening B.

Published in: Antimicrobial Resistance & Infection Control

Recurrent wheezing as a mediator between early-life exposures and childhood asthma: a mediation analysis in an Italian primary care paediatric cohort

2026

Authors: Boracchini R, Canova C, Bendoni S, Di Chiara C, Giaquinto C, Baraldi E, Cantarutti A.

Published in: BMJ Public Health

Dosing of ritonavir-boosted darunavir for treatment of HIV in pregnancy

2026

Authors: Sconza R, Taylor GP, Ene L, Kahlert C, van der Wekken-Pas L, Renaud F, Thorne C, Townsend CL.

Published in: AIDS

Intentions and attitudes of caregivers towards enrolment of their children and adolescents living with HIV into remission trials involving analytic treatment interruption

2026

Authors: Peay HL, Otwombe K, Barnabas S, Barrios-Tascon A, Lain MG, Nhampossa T, Rutebarika D, Jupimai T, Archary M, Maiga A-I, Violari A, Spyer MJ, Reddy K, Palma P, Pahwa S, Lichterfeld M, Cotton M, Kuhn L.

Published in: Journal of the International AIDS Society

Integrating life course perspectives into research involving people living with perinatally acquired HIV

2026

Authors: Toledo G, Le Prevost M, Judd A, Collins IJ.

Published in: BMC Global and Public Health

Perinatal HIV exposure is associated with long-term alterations in immune marker levels in children

2026

Authors: Avendaño-Ortiz J, Ventosa-Cubillo J, Rodríguez-Jiménez C, Morales-Pérez D, Muñoz-Hernández R, Pavía-Ruz N, Navarro ML, Holguín Á.

Published in: Journal of Infection and Public Health

Changes in pediatric primary care contacts: has the RSV-immunization modified the age-related access?

2026

Authors: Boracchini R, Barbieri E, Canova B, Baraldi E, Giaquinto C, Cantarutti A.

Published in: Italian Journal of Pediatrics

The evolving landscape of RSV immunization: Current policies and practices across Europe

2026

Authors: Franck Z, Hofstraat S, Jonker L, Kragten L, Messina C, Fernandes MR, Bruijning-Verhagen P, PIPELINE National Coordinators

Published in: Vaccine

Harmonizing Case Validation for Vaccine Safety in Real-World Data: The VAC4EU Experience

2026

Authors: Dehghan Tarazjani A, Weibel D, Aurelius T, Zwiers LC, Van den Berg JM, Pérez-Breva L, Gimeno-Miguel A, Stona L, Solórzano M, Desalegn AA, Poblador-Plou B, Lysen TS, Wheler J, Zidan M, Carreras JJ, Villalobos F, Ehrenstein V, Morton K, Rebordosa C, Ahmadizar F, Fortuny J, Arana A, Sturkenboom M.

Published in: Clinical Epidemiology

Weight gain, body composition, and metabolic parameters of dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: an ancillary analysis of the ODYSSEY trial

2026

Authors: Turkova A, White E, Violari A, Mujuru HA, Kekitiinwa AR, Lugemwa A, Kaudha E, Na-Rajsima S, Ahimbisibwe GM, Variavae E, Archary M, Akhalwaya Y, Puthanakit T, Bwakura-Dangarembizi M, Bbuye D, Kasozi M, Liberty A, Königs C, Welch SB, Riault Y, Bamford A, Cressey TR, Musoke P, Kityo C, Ferrand R, Giaquinto C, Rojo P, Gibb DM, Ford D; ODYSSEY trial team

Published in: The Lancet Child & Adolescent Health

Rapid Qualitative Approaches in Pandemic Research: Protocol for an Exploratory Qualitative Multimethod Study (VERDIQual) on Mpox in Italy, Nigeria, Thailand, and the United Kingdom

2026

Authors: Osa-Afiana C, Le Prevost M, Nicholls EJ, Bilardi D, Guadamuz TE, Soje-Amadosi EE, Adebisi GI, Adirieje C, Adetunji AA, Yusufu K, Witzel TC, Waratworawan W, Samoh N, May T, Denford S, Gomes W, Adirieje U, Tariq S, Sam-Agudu NA.

Published in: JMIR Research Protocols

Mobility-driven synthetic contact matrices as a scalable solution for real-time pandemic response modeling

2026

Authors: Di Domenico L, Bosetti P, Sabbatini CE, Opatowski L, Colizza V.

Published in: Nature Communications

Trial design and enrolment characteristics of LATA (long-acting treatment in adolescents): A randomised, open-label, non-inferiority, 96-week trial evaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen cabotegravir/ rilpivirine compared to daily oral therapy in virologically suppressed adolescents with HIV-1 infection, aged 12 to <20 years, in Sub-Saharan Africa

2026

Authors: Anena D, Chappell E, Nazzinda R, Kiilu C, Chitsamatanga M, Arumugam T, Green A, Mutuluuza CK, Bwakura-Dangarembizi M, Siika A, Archary M, Jafta L, Namukwaya S, Seeley J, Akabwai G, Mugerwa H, Bevers L, Burger D, Walker S, Bamford A, South A, Apoto N, Bush M, Thomason MJ, Spittle B, Ford D, Kekitiinwa AR, Pett SL; LATA Trial Team.

Published in: Contemporary Clinical Trials

Household SARS-CoV-2 transmission during Omicron wave in Chiang Mai, Thailand: a prospective observational study

2026

Authors: Khamduang W, Suebtam P, Collins IJ, Sripan P, Chalom K, Hongjaisee S, Kham-Kjing N, Wangsaeng N, Inmonthian P, Pinasu A, Kohklang N, Arnal M, Spyer M, Steffens-Westerhof I, Aramrattana A, Lallemant M, Angkurawaranon C, Bruijning-Verhagen P, Ngo-Giang-Huong N; Thailand VERDI-RECOVER Study Team.

Published in: The Lancet Regional Health – Southeast Asia

Associations between virus single or coinfections and respiratory symptoms in young children; a community-based cohort study

2025

Authors: Hauser-van Westrhenen E, Junquera Guinovart L, Schuurman R, van Boven M, Bonten M, Bruijning-Verhagen P.

Published in: International Journal of Infectious Diseases

Late diagnosis of paediatric HIV infection in high-income countries: Lessons from the HIV Perinatal Virtual Clinic

2025

Authors: Curto C, Tritzali M, Bamford A, Bailey AC, Lyall EGH, Mackie NE, Tickner N, Foster C; on behalf of the PVC.

Published in: HIV Medicine

Epidemiological characteristics of Monkeypox Virus Clade Ib in the Democratic Republic of Congo: the impact of transmission mode

2025

Authors: Kremer C, Nundu SS, Vakaniaki EH, Brosius I, Mukari G, Munganga P, Bangwen E, Mujula Y, De Vos E, Van Dijck C, Houben S, Gressani O, Kacita C, Mukadi-Bamuleka D, Muyembe-Tamfum JJ, Mbala-Kingebeni P, Liesenborghs L, Hens N, Torneri A.

Published in: Nature Communications

Short- and Long-term Humoral Response of Immunosuppressed Children to SARS-CoV-2 BNT162b2 Vaccine

2025

Authors: Tagarro A, Gastesi I, Hotterbeekx A, Aguilera-Alonso D, Konnova A, Gupta A, Salso S, Berkell M, Plata MdC, Domínguez-Rodríguez S, Ballesteros Á, Manzanares Á, Oltra M, Villanueva S, Pinto C, Guillén R, Giaquinto C, Moraleda C, Kumar-Singh S.

Published in: Pediatric Infectious Disease Journal

A rapid time-resolved host gene expression signature predicts responses to antibiotic treatment in neonatal bacterial sepsis

2025

Authors: Parkinson EC, Watkins WJ, Edkins S, McLaren JE, Clements MN, Andrews R, Liberatore F, Lutsar I, Turner MA, Roilides E, Heath PT, Sharland M, Hill LF, Ghazal P; on behalf of the NeoVanc Consortium.

Published in: Science Translational Medicine

BNT162b2 mRNA COVID-19 vaccine effectiveness in pregnancy: Emulating trial NCT04754594 using observational data from Norwegian health registries

2025

Authors: Zidan M, Trinh N, Desalegn A, Smith LH, van Gelder M, Nordeng H, Lupattelli A.

Published in: Vaccine

Risk factors for antibiotic resistant bacterial colonisation in European Neonatal Units – results of the NeoIPC feasibility study

2025

Authors: Minotti C, Cook A, Berkell M, Bielicki J, on behalf of the NeoIPC Consortium.

Presented at: jENS Congress 2025

Major revision version 13.0 of the European AIDS Clinical Society guidelines 2025

2025

Authors: Ambrosioni J, Levi LI, Alagaratnam J, Sempere A, Mastrangelo A, Paioni P, Mussini C, Marzolini C, Nielsen SD, Béguelin C, Welch S, Koval A, Mendao L, Bamford A, Calmy A, Guaraldi G, Oprea C, Martínez E, Rockstroh JK, The EACS Governing Board.

Published in: HIV Medicine

Transição precoce para Amoxicilina oral: seguro e eficaz em crianças hospitalizadas com Pneumonia Grave

2025

Presented by: Sidat M. M

Presented at: Jornadas Nacionais de Saude

Impacto da passagem oral à Amoxicilina ou Co-amoxiclav e da duração da terapêutica antibiótica na eficácia, segurança e selecção da resistência antibiótica na Pneumonia severa infantil adquirida na comunidade (PAC) – ensaio clínico PediCAP

2025

Presented by: Sidat M. M, em nome da equipe do ensaio PediCAP

Presented at: Simpósio Pré-Evento, XIII Conferência Científica da UEM

Pediatric stewardship in Italy: a necessity, not an option – a National Multi-Society Expert Consensus on Antimicrobial and Diagnostic Stewardship (SIP, SITIP, SIMRI, SIAIP, SIMEUP, SIPPS, SICUPP, SIMIT, SIMPE, SIPINF, SIT, SIAATIP, SARNEPI, AIEOP, SIM, SITI, SIF, SIFACT, SITA, SIN)

2025

Authors: Donà D, Barbieri E, Brigadoi G, Barchitta M, Berardi A, Bosis S, Buchini S, Buonsenso D, Cagliero A, Campana BR, Capello F, Carrozzo R, Castagnola E, Cazzato S, Cesaro S, Chiappini E, Colomba C, Comar M, De Alessandri A, De Luca M, Esposito B, Filograna MR, Franceschi A, Galli L, Garazzino S, Gemmi F, Gres E, Lancella L, Liberati C, Lo Vecchio A, Lo Giudice M, Marseglia G, Martelli G, Mengato D, Mercadante S, Meschiari M, Miraglia del Giudice M, Montagnani C, Muggeo P, Nicolini G, Nobili S, Pea F, Pedrotti D, Reggiani L, Sambri V, Sanguinetti M, Santiloni A, Silvani MC, Vatiero L, Zama D, Zampogna S, Zanai R, Esposito S.

Published in: Italian Journal of Pediatrics

Changes in body mass index in children and adolescents living with HIV in Europe and Thailand starting dolutegravir 

2025

Authors: Edgar K, The Epidemiology of Pregnancy and Paediatric Infections International Cohort Collaboration (EPPICC) study group

Published in: Open Forum Infectious Diseases

Mpox-related hospitalization and morbidity in people living with HIV and PrEP users: results from the European MASH-1 cohort study

2025

Authors: Nicoló Girometti on behalf of the MASH-1 study group.

Presented at: European AIDS Conference (EACS) 2025

Effectiveness and safety of tenofovir alafenamide fumarate–based therapy compared to tenofovir disoproxil fumarate- and abacavir-based therapy in children and young people living with HIV in Europe

2025

Authors: Chappell E, The European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) Study Group

Published in: International Journal of Antimicrobial Agents

Antifungal Prescribing in European Pediatric Intensive Care Units: Results of a multinational 3-month weekly point-prevalence survey

2025

Authors: Chorafa E, Iosifidis E, Alkhaaldi AA, Arias A, Cetin BS, De Luca M, Emonts M, Ferreras-Antolin L, Ghimenton-Walters E, Grasa CD, Groll AH, Herrera-Castillo L, Lehrnbecher T, Manzanares A, Masjosthusmann K, Melendo S, Mendoza-Palomar N, Paulus S, Rincón-López E, Romani L, Sdougka M, Solopova G, Strenger V, Tedford K, Tzika C, Warris A, Zsigmond B, Roilides E.

Published in: Journal of the Pediatric Infectious Diseases Society

Once-daily dolutegravir/lamivudine fixed-dose formulations in children living with HIV: a pharmacokinetic and safety sub-study nested in the open-label, multicentre, randomised, non-inferiority D3/PENTA 21 trial

2025

Authors: Bevers LAH, Toledo G, Kisekka M, Kaudha E, Ahimbisibwe GM, Deprez I, Arumugan T, Variava E, Violari A, White I, Bbuye D, Nanduudu A, Mulwanyi E, Amuge P, Rutebarika DA, Kekitiinwa A, Kityo C, Musoke P, Archary M, Boles J, Thomason MJ, de Wildt SN, Giaquinto C, Colbers A, Burger DM, Buchanan AM, Chan MK, Jacobs TG, Turkova A on behalf of the D3 TRIAL TEAM

Published in: eBioMedicine

Representations of mpox by healthcare professionals and scientists on TikTok: a qualitative analysis of TikTok content

2025

Authors: Nicholls EJ, Le Prevost M, Gomes W, Witzel TC, Bilardi D, Denford S, May T, Tariq S.

Published in: Journal of Medical Internet Research

Long COVID and post-viral fatigue syndrome recorded in children and young people in England primary care, 2006-2022

2025

Authors: Raveendran V, Thorne C, Jackson C, Hardelid P.

Presented at: Administrative Data Research UK (ADR UK) Conference

Impact of the COVID-19 pandemic and the introduction of mRNA vaccines against COVID-19 infection on uptake of childhood vaccines in Norway

2025

Authors: Trinh NTH, Lupattelli A.

Presented at: European Perinatal and Paediatric Epidemiology Conference (EPPEC)

Lessons from the European Mpox Outbreak: Strengthening Cohort Research for Future Pandemic Preparedness

2025

Authors: Visentin A, Nazeri A, Peñalvo JL, Gorska A, Davis RJ, Flett RL, Simensen VC, Langeland N, Gaday Q, Mirandola M, Mazzotta V, Nguyen LBL, Mothe B, Van Dijck C, Meyerhans A, Boesecke C, Giaquinto C, Judd A, Tacconelli E.

Published in: Clinical Microbiology and Infection

The prevalence and seasonal distribution of respiratory viruses, including SARS-CoV-2, in South African children with respiratory tract infections

2025

Authors: McGregor S, Claasen M, Barday M-A, van Niekerk M, Redfern A, Verhagen LM, Rabie H, van der Zalm MM, Hulsman C.

Presented at: Stellenbosch University Academic Year Day

Diarrhoeal admissions among children aged <5 years in public sector facilities in Western Cape Province, South Africa, before and during the COVID-19 pandemic (2019-2021)

2025

Authors: Kehoe K, Morden E, Zinyakatira N, Heekes A, Jones HE, Walter SR, Jacobs T, Murray J, Buys H, Eley B, Redaniel T, Davies M-A.

Published in: South African Medical Journal

Nonparametric serial interval estimation with uniform mixtures

2025

Authors: Gressani O, Hens N.

Published in: PLOS Computational Biology

Adolescents in phase 3 HIV clinical trials

2025

Authors: Foster C, Ruel T, Ford D, Turner RM, Archary M, Rojo P, Gibb D; Penta-IMPAACT.

Published in: The Lancet Child & Adolescent Health

Research gaps for children who are HIV-exposed but uninfected: outcomes of a research prioritisation workshop

2025

Authors: Wedderburn CJ, Evans C, Abrams EJ, Bamford A, Bekker A, Bunders MJ, Epalza C, Foster C, Frigati L, Goetghebuer T, John-Stewart G, Kahlert CR, Moraleda C, Musiime V, Namiba A, Nastouli E, Njuguna I, Pahwa SG, Rabie H, Sainz T, Serghides L, Shibemba M, Tsondai P, Powis K, Thorne C, Prendergast AJ.

Published in: The Lancet HIV

Weight gain on tenofovir alafenamide fumarate‐based therapy compared to tenofovir disoproxil fumarate‐ and abacavir‐based therapy in children and young people living with HIV in Europe

2025

Authors: The European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) Study Group

Published in: HIV Medicine

12345678910111213141516